Valproic Acid Solution
Product Images NDC 68999-196

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valproic Acid (NDC 68999-196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Governmental & Specialty Rx, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Valproic Acid Oral Solution 10ml Unit Dose Label)

"image Description" (Valproic Acid Oral Solution 10ml Unit Dose Label)
Label of Valproic Acid oral solution, USP, 500 mg/10 mL strength. The label indicates it delivers 10 mL and states Rx only. It is manufactured for Chartwell Governmental & Specialty RX, LLC, Congers, NY. Additional details include NDC 68999-874-59, lot number, expiration date, and a barcode. The label notes use for institutional purposes only and advises to see insert/MedGuide.*
FDA Label Image

"image Description" (Valproic Acid Oral Solution 5ml Unit Dose Label)

"image Description" (Valproic Acid Oral Solution 5ml Unit Dose Label)
Label for Valproic Acid oral solution, USP, 250 mg per 5 mL. The round label states it delivers 5 mL, includes an NDC number 68999-196-45, and indicates it is for institutional use only. Manufactured for Chartwell Governmental & Specialty RX, LLC. Directions to see insert or MedGuide are included along with space for lot number and expiration date.*
FDA Label Image

"image Description" (Valproic Acid Oral Solution Figure 1)

"image Description" (Valproic Acid Oral Solution Figure 1)
A line graph labeled Figure 1 depicting the percentage reduction in CPS Rate versus the percentage of patients. Two curves are shown: one solid line for Divalproex Sodium and one dashed line for Placebo. The vertical axis ranges from -100% (worsening) to 100% (improvement), with 0% indicating no change. The horizontal axis ranges from 100% to 0% of patients, illustrating comparative treatment effects.*
FDA Label Image

"image Description" (Valproic Acid Oral Solution Figure 2)

"image Description" (Valproic Acid Oral Solution Figure 2)
A line chart depicting the percentage reduction in CPS rate versus the percentage of patients, comparing high dose and low dose groups. The y-axis shows improvement and worsening, while the x-axis shows the percentage of patients from 0 to 100%. Two lines represent high dose (solid) and low dose (dotted) responses over the patient population.*
FDA Label Image

"image Description" (Valproic Acid Oral Solution Structure)

"image Description" (Valproic Acid Oral Solution Structure)
Chemical structure diagram of valproic acid showing its molecular arrangement including carbon chains and a carboxylic acid group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.